Literature DB >> 7906891

D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats.

B E Garrett1, S G Holtzman.   

Abstract

The mechanism of action for the behavioral stimulant effects of caffeine has been extensively studied, but results have been ambiguous and inconsistent. The present study examined the role of dopamine in caffeine-induced stimulation of locomotor activity in rats. d-Amphetamine was also tested for comparison. Locomotor activity of male Sprague-Dawley rats (300-350 g) was measured using two-channel electronic activity monitors. Activity counts were recorded for 30 min following a 30-min pretreatment with either caffeine (3.0-100 mg/kg, IP) or d-amphetamine (0.1-3.0 mg/kg, IP) alone and in combination with the D1 dopamine antagonist SCH23390 (0.01 and 0.003 mg/kg, SC) or the D2 dopamine antagonists sulpiride (30 mg/kg, SC) or eticlopride (0.03 mg/kg, SC). Caffeine and d-amphetamine dose dependently increased locomotor activity. This effect of both caffeine and d-amphetamine was blocked by SCH23390 as well as by eticlopride. Sulpiride blocked the stimulatory effects of caffeine but not d-amphetamine. These results suggest that the locomotor stimulant effect of caffeine, like that of d-amphetamine, is mediated through dopaminergic systems; both D1 and D2 receptors appear to be involved.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7906891     DOI: 10.1016/0091-3057(94)90115-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  31 in total

1.  Functional uncoupling of adenosine A(2A) receptors and reduced responseto caffeine in mice lacking dopamine D2 receptors.

Authors:  N R Zahniser; J K Simosky; R D Mayfield; C A Negri; T Hanania; G A Larson; M A Kelly; D K Grandy; M Rubinstein; M J Low; B B Fredholm
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Effects of aripiprazole on caffeine-induced hyperlocomotion and neural activation in the striatum.

Authors:  Luara A Batista; Thércia G Viana; Vívian T Silveira; Daniele C Aguiar; Fabrício A Moreira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-29       Impact factor: 3.000

Review 3.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

4.  Effects of amphetamine exposure during adolescence on behavior and prelimbic cortex neuron activity in adulthood.

Authors:  Luke K Sherrill; Joshua M Gulley
Journal:  Brain Res       Date:  2018-05-21       Impact factor: 3.252

5.  Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice.

Authors:  Christopher S Tallarida; Gladys Corley; Jane Kovalevich; William Yen; Dianne Langford; Scott M Rawls
Journal:  Neurosci Lett       Date:  2013-10-11       Impact factor: 3.046

6.  Discriminative stimulus properties of tianeptine.

Authors:  Tevfik Alici; Hakan Kayir; M Oguz Aygoren; Esra Saglam; I Tayfun Uzbay
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

7.  The role of adenosine receptors in the central action of caffeine.

Authors:  John W Daly; Dan Shi; Olga Nikodijevic; Kenneth A Jacobson
Journal:  Pharmacopsychoecologia       Date:  1994

8.  Effects of caffeine on persistence and reinstatement of nicotine-seeking behavior in rats: interaction with nicotine-associated cues.

Authors:  Xiu Liu; Courtney Jernigan
Journal:  Psychopharmacology (Berl)       Date:  2011-09-27       Impact factor: 4.530

Review 9.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

10.  Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease.

Authors:  M Morelli; J Wardas
Journal:  Neurotox Res       Date:  2001-11       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.